
Global Regulatory Track
Interact with global regulators to create a new, more efficient collaborative paradigm to share information, experiences, and develop strategies to improve medical product development. This track seeks to establish mechanisms to facilitate the exchange of information, share best practices, identify commonalities, and develop approaches to overcome regulatory barriers.• CDER Town Hall: Parts 1 and 2
• CBER Town Hall
• European Town Hall: Parts 1 and 2
• Indian Town Hall
• International Regulatory Cooperation: A Canadian Perspective
• Latin American Town Hall
• Pediatric Drug Development Progress: 15 Years Later and Across the Globe
• Pharmaceuticals and Medical Devices Agency (PMDA) Town Hall
• SFDA Town Hall
• State of Electronic Submissions at CDER, CBER, and CDRH
• Update from the EMA-FDA Parallel Assessment Pilot
• Update on EMA, FDA, and PMDA International Activities
For more details, please visit Global Regulatory offerings at DIA 2012.
No comments:
Post a Comment